IRIS
LOMBARDI, RAFFAELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.778
NA - Nord America 1.295
EU - Europa 1.195
SA - Sud America 266
AF - Africa 40
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.579
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.255
SG - Singapore 1.016
RU - Federazione Russa 632
CN - Cina 347
BR - Brasile 217
IT - Italia 200
HK - Hong Kong 159
VN - Vietnam 148
DE - Germania 75
NL - Olanda 66
UA - Ucraina 59
FI - Finlandia 42
KR - Corea 24
GB - Regno Unito 22
AR - Argentina 21
IE - Irlanda 20
IN - India 18
MX - Messico 15
PL - Polonia 15
ZA - Sudafrica 15
AT - Austria 14
CA - Canada 14
SE - Svezia 11
EC - Ecuador 9
JP - Giappone 9
ES - Italia 7
FR - Francia 7
IQ - Iraq 7
UZ - Uzbekistan 7
BD - Bangladesh 6
CI - Costa d'Avorio 6
PY - Paraguay 6
BG - Bulgaria 5
ID - Indonesia 5
CO - Colombia 4
SA - Arabia Saudita 4
BE - Belgio 3
CL - Cile 3
GE - Georgia 3
IL - Israele 3
LT - Lituania 3
MA - Marocco 3
MY - Malesia 3
AE - Emirati Arabi Uniti 2
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
CR - Costa Rica 2
DK - Danimarca 2
GA - Gabon 2
GF - Guiana Francese 2
JO - Giordania 2
KE - Kenya 2
LC - Santa Lucia 2
ML - Mali 2
NP - Nepal 2
PK - Pakistan 2
TN - Tunisia 2
VE - Venezuela 2
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
BZ - Belize 1
CU - Cuba 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MR - Mauritania 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SD - Sudan 1
SN - Senegal 1
SV - El Salvador 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.579
Salva come PNG Salva come JPEG
Città #
Singapore 520
Hong Kong 159
Moscow 159
Santa Clara 148
Chandler 139
Hefei 117
Beijing 97
Ashburn 88
Naples 60
Amsterdam 57
Jacksonville 51
Boston 44
Los Angeles 44
Ho Chi Minh City 42
Millbury 36
Woodbridge 35
Hanoi 32
Munich 32
San Jose 32
Lawrence 25
Redondo Beach 25
Buffalo 24
Des Moines 24
Seoul 23
Princeton 21
São Paulo 19
The Dalles 19
Nanjing 18
Rome 18
Wilmington 17
Dong Ket 16
Denver 15
Florence 15
Houston 15
New York 11
Turku 11
Warsaw 11
Dublin 10
Napoli 10
Brasília 9
Mexico City 9
Belo Horizonte 8
Brooklyn 8
Lappeenranta 8
Milan 8
Nuremberg 8
Rio de Janeiro 8
Da Nang 7
Orem 7
Tashkent 7
Tokyo 7
Atlanta 6
Capaccio 6
Chicago 6
Turin 6
Chennai 5
Dallas 5
Fairfield 5
Frankfurt am Main 5
Haiphong 5
Helsinki 5
Mugnano di Napoli 5
Poplar 5
San Francisco 5
Vienna 5
Ann Arbor 4
Cernobbio 4
Curitiba 4
Goiânia 4
Hebei 4
Montreal 4
Nanchang 4
Ottawa 4
Seattle 4
Shenyang 4
Sofia 4
Stockholm 4
Thái Bình 4
Cape Town 3
Charlotte 3
Council Bluffs 3
Córdoba 3
Falkenstein 3
Fortaleza 3
Grumo Nevano 3
Guangzhou 3
Guayaquil 3
Hải Dương 3
Jiaxing 3
Johannesburg 3
London 3
Manchester 3
Mumbai 3
Norwalk 3
Phoenix 3
Sarno 3
Tampa 3
Thái Nguyên 3
Toronto 3
Wroclaw 3
Totale 2.525
Salva come PNG Salva come JPEG
Nome #
Dobutamine stress echocardiography in hypertrophic cardiomyopathy 125
Myocardial collagen turnover in hypertrophic cardiomyopathy 123
Echocardiographic Strain Abnormalities Precede Left Ventricular Hypertrophy Development in Hypertrophic Cardiomyopathy Mutation Carriers 113
Abnormal blood-pressure response to exercise and oxygen consumption in patients with hypertrophic cardiomyopathy 113
Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. 111
Sarcomeric versus Non-Sarcomeric HCM 108
Speckle-tracking analysis based on 2D echocardiography does not reliably measure left ventricular torsion 107
Hemodynamic effects of isometric exercise in hypertrophic cardiomyopathy: comparison with normal subjects 106
Long-term follow-up study on obstructive hypertrophic cardiomyopathy patients treated with disopyramide: evidences of a notable trend in symptom control within a real-world clinical setting 102
Global longitudinal strain in pre-symptomatic patients with mutation for transthyretin amyloidosis 102
Myocardial texture in hypertrophic cardiomyopathy 98
Left Ventricular Mass in Hypertrophic Cardiomyopathy Assessed by 2D-Echocardiography: Validation with Magnetic Resonance Imaging 98
Diagnosis and Clinical Implication of Left Ventricular Aneurysm in Hypertrophic Cardiomyopathy 97
Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes 95
Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy 94
Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function 94
Artificial intelligence-driven electrocardiography: Innovations in hypertrophic cardiomyopathy management 93
Aetiology and pathogenesis of hypertrophic cardiomyopathy 91
Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms. 90
Myocardial collagen turnover in hypertrophic cardiomyopathy 90
Percutaneous treatment of patients with heart diseases: selection, guidance and follow-up. A review 89
Characterization of Hypertrophic Cardiomyopathy Caused by Mutations in Four and a Half Lim Domains 1 Gene 87
Effect of hypertrophy on left ventricular diastolic function in patients with hypertrophic cardiomyopathy. 87
Distinct Cellular Basis for Early Cardiac Arrhythmias, the Cardinal Manifestation of Arrhythmogenic Cardiomyopathy, and the Skin Phenotype of Cardiocutaneous Syndromes 86
Clinical significance of diastolic dysfunction and the effect of therapeutic interventions 85
Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy 82
Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation 82
Diagnosis and Treatment of Obstructive Hypertrophic Cardiomyopathy 82
Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy 80
Comparison of hemodynamic adaptation to orthostatic stress in patients with hypertrophic cardiomyopathy with or without syncope and in vasovagal syncope 78
Suppression of canonical Wnt/β-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy 78
[Myocardial interstitial fibrosis and diastolic dysfunction in hypertrophic cardiomyopathy]. 76
Knock Down of Plakophillin 2 Dysregulates Adhesion Pathway through Upregulation of miR200b and Alters the Mechanical Properties in Cardiac Cells 76
Myocardial interstitial fibrosis and diastolic dysfunction in hypertrophic cardiomyopathy,Fibrosi interstiziale miocardica e disfunzione diastolica nella cardiomiopatia ipertrofica 75
Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: A pilot study 74
Mechano-energetic efficiency in patients with hypertrophic cardiomyopathy with and without sarcomeric mutations 73
Arrhythmogenic Cardiomyopathy and Skeletal Muscle Dystrophies: Shared Histopathological Features and Pathogenic Mechanisms 68
Filamin C Deficiency Impairs Sarcomere Stability and Activates Focal Adhesion Kinase through PDGFRA Signaling in Induced Pluripotent Stem Cell-Derived Cardiomyocytes 60
Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis 59
Deletion of the Lmna gene in fibroblasts causes senescence-associated dilated cardiomyopathy by activating the double-stranded DNA damage response and induction of senescence-associated secretory phenotype 58
Human molecular genetic and functional studies identify TRIM63, encoding muscle RING finger protein 1, as a novel gene for human hypertrophic cardiomyopathy 57
Enhanced transmural fiber rotation and connexin 43 heterogeneity are associated with an increased upper limit of vulnerability in a transgenic rabbit model of human hypertrophic cardiomyopathy 56
Identification of Genes and Pathways Regulated by Lamin A in Heart 56
Editorial of Special Issue “Genetics and Molecular Pathogenesis of Non-Ischemic Cardiomyopathies” 56
DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated with LMNA (Lamin A/C) Mutations 55
Activation of PDGFRA signaling contributes to filamin C-related arrhythmogenic cardiomyopathy 55
Cardiac fibro-adipocyte progenitors express desmosome proteins and preferentially differentiate to adipocytes upon deletion of the desmoplakin gene 52
The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy 49
Knockdown of plakophilin 2 downregulates MIR-184 through CpG hypermethylation and suppression of the E2F1 pathway and leads to enhanced adipogenesis in vitro 48
Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies 47
Arrhythmogenic right ventricular cardiomyopathy is a disease of cardiac stem cells 47
Genetics and sudden death 47
Suppression of activated FOXO transcription factors in the heart prolongs survival in a mouse model of laminopathies. 46
Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy 45
Established and emerging mechanisms in the pathogenesis of arrhythmogenic cardiomyopathy: A multifaceted disease 45
A polygenic risk score after corrective surgery for transposition of the great arteries: Can genetics add value to clinical predictors of outcome? 44
Haploinsufficiency of Tmem43 in cardiac myocytes activates the DNA damage response pathway leading to a late-onset senescence-associated pro-fibrotic cardiomyopathy 44
Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy 42
Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy 42
Molecular genetics and pathogenesis of arrhythmogenic right ventricular cardiomyopathy: A disease of cardiac stem cells 37
Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity 36
Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy 35
Molecular and cellular mechanisms in heart failure including models of heart failure 33
NFkB1 Pathway is a Major Dysregulated Biological Pathway in Cardiac Myocytes in Myocyte-Specific Lamin A/C Deficient Mice 29
Totale 4.688
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.584
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.584
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202169 0 0 0 0 0 0 10 0 17 13 13 16
2021/2022220 0 0 0 0 0 7 0 11 21 36 40 105
2022/2023334 48 24 17 11 46 35 0 33 38 59 17 6
2023/2024202 6 31 46 12 9 10 2 18 2 2 40 24
2024/20251.684 88 150 2 15 92 86 200 119 78 139 542 173
2025/20261.880 310 292 325 281 497 132 43 0 0 0 0 0
Totale 4.688